Collegium Pharmaceutical Garners $50,000,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=42e4c741-c8c6-4b4d-8049-ce5f38b61a43
Date
3/11/2015
Company Name
Collegium Pharmaceutical
Mailing Address
780 Dedham Street Canton, MA 02021 USA
Company Description
Collegium Pharmaceutical is dedicated to the development of proprietary, late stage pharmaceutical products that add market value and clinical benefit to existing drugs.
Website
http://www.collegiumpharma.com
Transaction Type
Venture Equity
Transaction Amount
$50,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Collegium plans to use the proceeds of this financing to advance its lead abuse-deterrent product candidate, Xtampza ER (oxycodone extended-release capsules), through potential FDA approval and commercial launch as well as to fund operational growth and other pipeline development programs.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor